Insider trades
Kevin Puylaert, Chief Officer of SOPHiA Genetics SOPH, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $3,520. The latest trade was on 05/19.
Kevin Puylaert
Chief Sales Officer
- Company
- SOPHiA Genetics SOPH
- First filing
- 26/03/20
- Trades
- 11 trades
- Buys / sales
- 0 / 7
- 12-month net buying
- −$3,520
- Last trade
- 05/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
SOPHiA GeneticsSOPH | Open-market sale | 05/19 | 05/20 | 33 sh | $4.54 | $149.82 | −0.0% |
SOPHiA GeneticsSOPH | Open-market sale | 04/20 | 04/21 | 33 sh | $5.08 | $167.64 | −0.0% |
SOPH | Open-market sale | 04/06 | 04/08 | 624 sh3 trades | $4.86avg. | $3,031.74 | −0.4% |
SOPHiA GeneticsSOPH | Open-market sale | 03/31 | 04/01 | 3 sh | $4.71 | $14.13 | −0.0% |
SOPHiA GeneticsSOPH | Open-market sale | 03/19 | 03/20 | 33 sh | $4.76 | $157.08 | −0.0% |